Literature DB >> 12615485

Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue engineering.

G Torun Köse1, H Kenar, N Hasirci, V Hasirci.   

Abstract

Macroporous poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV) matrices were prepared after solvent evaporation and solute leaching. PHBV solutions with different concentrations were prepared in chloroform: dichloromethane (1:2, v/v). In order to create a matrix with high porosity and uniform pore sizes, sieved sucrose crystals (75-300 or 300-500 microm) were used. PHBV foams were treated with rf-oxygen plasma to modify their surface chemistry and hydrophilicity with the aim of increasing the reattachment of osteoblasts. Surface characteristics, pore sizes and their distribution on PHBV surface were studied by scanning electron microscopy (SEM) and Scion Image Analysis Program. Void volume, pore sizes and density of foams were found to be significantly affected by foam preparation conditions. Stability of PHBV foams in aqueous media was studied. Their weight and density were unchanged for a period of 120 days and then a significant decrease was observed for the rest of the study (60 days). Osteoblasts were seeded onto the foams and their proliferation inside the matrices was also determined by SEM. After 29 and 60 days of incubation, growth of osteoblasts on matrices was observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615485     DOI: 10.1016/s0142-9612(02)00613-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

1.  Biocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) modified by silk fibroin.

Authors:  Na Mei; Ping Zhou; Luan-Feng Pan; Guang Chen; Chun-Gen Wu; Xin Chen; Zheng-Zhong Shao; Guo-Qiang Chen
Journal:  J Mater Sci Mater Med       Date:  2006-08       Impact factor: 3.896

2.  Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration.

Authors:  Pinar Yilgor; Rui A Sousa; Rui L Reis; Nesrin Hasirci; Vasif Hasirci
Journal:  J Mater Sci Mater Med       Date:  2010-08-26       Impact factor: 3.896

3.  Nanomaterials and nanotechnology for skin tissue engineering.

Authors:  Aezeden Mohamed; Malcolm Mengqiu Xing
Journal:  Int J Burns Trauma       Date:  2012-03-15

4.  Hydroxyapatite nanorod-reinforced biodegradable poly(L-lactic acid) composites for bone plate applications.

Authors:  Erkin Aydin; Josep A Planell; Vasif Hasirci
Journal:  J Mater Sci Mater Med       Date:  2011-09-15       Impact factor: 3.896

5.  In vitro biocompatibility assessment of PHBV/Wollastonite composites.

Authors:  Haiyan Li; Wanying Zhai; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

6.  Hydroxyapatite containing superporous hydrogel composites: synthesis and in-vitro characterization.

Authors:  T Tolga Demirtaş; Ayşe Gönen Karakeçili; Menemşe Gümüşderelioğlu
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

7.  Increased response of Vero cells to PHBV matrices treated by plasma.

Authors:  Carolina Lucchesi; Betina M P Ferreira; Eliana A R Duek; Arnaldo R Santos; Paulo P Joazeiro
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

Review 8.  Manipulating biological agents and cells in micro-scale volumes for applications in medicine.

Authors:  Savas Tasoglu; Umut Atakan Gurkan; Shuqi Wang; Utkan Demirci
Journal:  Chem Soc Rev       Date:  2013-07-07       Impact factor: 54.564

9.  An Investigation of the Interaction between Bovine Serum Albumin-Conjugated Silver Nanoparticles and the Hydrogel in Hydrogel Nanocomposites.

Authors:  Berhanu Zewde; Olufolasade Atoyebi; Ayele Gugssa; Karen J Gaskell; Dharmaraj Raghavan
Journal:  ACS Omega       Date:  2021-04-22

10.  Preparation and characterization of superporous hydrogels as gastroretentive drug delivery system for rosiglitazone maleate.

Authors:  N Vishal Gupta; H G Shivakumar
Journal:  Daru       Date:  2010       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.